Genetic testing
CA 2378616 A1 · Owner: Brenchley, Paul Ernest Charles · Inventors: Watson, Carolyn; Brenchley, Paul Ernest Charles
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to an in vitro method for diagnosing or detecting a predisposition to a disease or disorder associated with abnormal Vascular Endothelial Growth Factor gene expression and kits for use in such a method. The method comprises examining regulatory elements associated with the Vascular Endothelial Growth Factor gene to detect the presence of a genetic polymorphism which is linked to the disease or disorder.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 6, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 6, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 6, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.